US Patent Issued to Ebenbuild on July 15 for "Method for assessing the efficacy of an aerosol for pulmonary drug delivery as well as inhaler device, orally inhaled and/or nasal drug product and drug/device combination product" (German Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,357,775, issued on July 15, was assigned to Ebenbuild GmbH (Munich).

"Method for assessing the efficacy of an aerosol for pulmonary drug delivery as well as inhaler device, orally inhaled and/or nasal drug product and drug/device combination product" was invented by Jonas Biehler (Grafing b. Munich, Germany), Karl-Robert Klaus Wichmann (Munich), Kei Wieland Muller (Munich), David Rudlstorfer (Munich), Maximilian Josef Grill (Munich) and Jakob Richter (Munich).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to systems and methods for assessing the efficacy of an aerosol for pulmonary drug delivery as well as to an inhaler device, an o...